[PDF] Monitoring usage in Wales of medicines appraised by NICE and AWMSG

All Wales Medicines Strategy Group - AWMSG
All Wales Medicines Strategy Group (AWMSG)
Publication date:
01 November 2016


As of March 2016, 280 medicines had received a positive recommendation for use in Wales by AWMSG and/or NICE for one or more indications, costing NHS Wales £247 million for the financial year 2015–2016. This report focuses on the 158 medicines that have received a positive recommendation in the three years to March 2016.